Imai Y - Search Results

1

[CLINICAL OUTCOMES OF CUTANEOUS VESICOSTOMY IN PEDIATRIC UROLOGICAL DISEASES].

Kobayashi D, Hasegawa Y, Imai Y, Kasai K, Kimura T, Egawa S. Kobayashi D, et al. Among authors: imai y. Nihon Hinyokika Gakkai Zasshi. 2019;110(4):230-233. doi: 10.5980/jpnjurol.110.230. Nihon Hinyokika Gakkai Zasshi. 2019. PMID: 33087683 Free article. Japanese.

2

[A Case of Renal Cell Carcinoma Choroidal Metastasis Diagnosed from Vision Disorders].

Imai Y, Matsuura T, Hisakane A, Moritake J, Bando S, Yamada H, Kiyota H, Iida K, Egawa S. Imai Y, et al. Hinyokika Kiyo. 2019 Feb;65(2):33-37. doi: 10.14989/ActaUrolJap_65_2_33. Hinyokika Kiyo. 2019. PMID: 31067840 Free article. Japanese.

3

No survival benefit found after extended treatment with docetaxel for patients with castration-resistant prostate cancer.

Tanaka M, Kimura T, Iwamura Y, Enei Y, Iwamoto Y, Imai Y, Inaba Y, Matsukawa A, Onuma H, Ito K, Mori K, Sasaki H, Miki J, Furuta A, Miki K, Egawa S. Tanaka M, et al. Among authors: imai y. Prostate. 2019 Oct;79(14):1604-1610. doi: 10.1002/pros.23884. Epub 2019 Aug 2. Prostate. 2019. PMID: 31376184

4

Improved health-related quality of life in patients treated with topical sirolimus for facial angiofibroma associated with tuberous sclerosis complex.

Hatano T, Ohno Y, Imai Y, Moritake J, Endo K, Tamari M, Egawa S. Hatano T, et al. Among authors: imai y. Orphanet J Rare Dis. 2020 Jun 1;15(1):133. doi: 10.1186/s13023-020-01417-5. Orphanet J Rare Dis. 2020. PMID: 32487130 Free PMC article.

5

Effectiveness of pembrolizumab in patients with urothelial carcinoma receiving proton pump inhibitors.

Fukuokaya W, Kimura T, Komura K, Uchimoto T, Nishimura K, Yanagisawa T, Imai Y, Iwatani K, Ito K, Urabe F, Tsuzuki S, Kimura S, Terada N, Mukai S, Oyama Y, Abe H, Kamoto T, Azuma H, Miki J, Egawa S. Fukuokaya W, et al. Among authors: imai y. Urol Oncol. 2022 Jul;40(7):346.e1-346.e8. doi: 10.1016/j.urolonc.2022.02.020. Epub 2022 Mar 26. Urol Oncol. 2022. PMID: 35346571

6

Laparoscopic partial nephrectomy for the horseshoe kidney with indocyanine green fluorescence guidance under the modified supine position.

Imai Y, Urabe F, Fukuokaya W, Matsukawa A, Iwatani K, Aikawa K, Obayashi K, Yanagisawa T, Tsuzuki S, Nakajo H, Kimura T, Egawa S, Miki J. Imai Y, et al. IJU Case Rep. 2022 Apr 26;5(4):259-262. doi: 10.1002/iju5.12450. eCollection 2022 Jul. IJU Case Rep. 2022. PMID: 35795128 Free PMC article.

7

Effectiveness of pembrolizumab in trial-ineligible patients with metastatic urothelial carcinoma.

Fukuokaya W, Yanagisawa T, Hashimoto M, Yamamoto S, Koike Y, Imai Y, Iwatani K, Onuma H, Ito K, Urabe F, Tsuzuki S, Kimura S, Miki J, Oyama Y, Abe H, Kimura T. Fukuokaya W, et al. Among authors: imai y. Cancer Immunol Immunother. 2023 Apr;72(4):841-849. doi: 10.1007/s00262-022-03291-5. Epub 2022 Sep 14. Cancer Immunol Immunother. 2023. PMID: 36102985 Free PMC article.

8

Comparison of outcomes in high-risk prostate cancer patients treated with low-/high-dose-rate brachytherapy plus external beam radiotherapy.

Imai Y, Urabe F, Iwatani K, Nakazono M, Tashiro K, Honda M, Aoki M, Sato S, Takahashi H, Miki K, Kimura T. Imai Y, et al. Int J Clin Oncol. 2023 May;28(5):698-706. doi: 10.1007/s10147-023-02314-0. Epub 2023 Feb 22. Int J Clin Oncol. 2023. PMID: 36814038

9

Patients with PSA below 0.2 ng/mL at 8 years post high-dose-rate brachytherapy have an extremely low risk of subsequent recurrence.

Nakazono M, Urabe F, Iwatani K, Imai Y, Tashiro K, Honda M, Koike Y, Shimomura T, Sato S, Takahashi H, Miki K, Aoki M, Kimura T. Nakazono M, et al. Among authors: imai y. Int J Urol. 2023 Dec;30(12):1147-1154. doi: 10.1111/iju.15289. Epub 2023 Aug 31. Int J Urol. 2023. PMID: 37650359

10

The Efficacy and Safety of a Low Relative Dose Intensity of Cabazitaxel in Patients With Metastatic Castration-resistant Prostate Cancer.

Urabe F, Kobayashi D, Iwatani K, Imai YU, Onuma H, Aikawa K, Yanagisawa T, Tashiro K, Sasaki H, Miki J, Miki K, Kimura T. Urabe F, et al. Among authors: imai yu. Anticancer Res. 2023 Oct;43(10):4611-4617. doi: 10.21873/anticanres.16655. Anticancer Res. 2023. PMID: 37772549

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,620 results

Search Page

Filters